Compositions and methods for bioengineered tissues

Patent metadata

Field	Value
Publication number	US-2017369849-A1
Application number	US-201715586061-A
Country	US
Kind code	A1
Filing date	May 3, 2017
Priority date	May 11, 2016
Publication date	Dec 28, 2017
Grant date	—

Abstract

The present disclosure provides methods for producing bioengineered tissue along with an apparatus and other relevant compositions employed in generation thereof.

First claim

What is claimed is:

1 . A container for the generation of bioengineered tissue, where the generation comprises introducing epithelial and mesenchymal cells into or onto a biomatrix scaffold, wherein the biomatrix scaffold comprises collagens.

2 . The container of claim 1 , in which epithelial and mesenchymal cells are maturational lineage partners.

3 . The container of claim 1 , in which epithelial and mesenchymal cells are in a seeding medium, and the seeding medium is replaced with a differentiation medium after an initial incubation period.

4 . The container of claim 3 , where in the differentiation medium comprises:
a. A basal medium, b. Lipids, insulin, transferrin, antioxidants, c. Copper, d. Calcium, e. One or more signals for the propagation or maintenance of epithelial cells, and/or f. One or more signals for the propagation or maintenance of mesenchymal cells.

5 . The container of claim 3 in which the seeding medium is serum-free or is supplemented with between about 2% to 10% fetal serum, optionally over the duration of a few hours.

6 . The container of claim 3 , where in the seeding medium comprises:
a. A basal medium b. Lipids c. Insulin d. Transferrin e. Antioxidants.

7 . The container of claim 3 in which the epithelial and mesenchymal cells in the seeding medium is incubated at 4° C. in the seeding medium for 4 to 6 hours prior to introduction into the biomatrix scaffolds

8 . The container of claim 1 , in which the biomatrix scaffold is three-dimensional

9 . The container of claim 1 , in which the collagens in the biomatrix scaffold comprise (i) nascent collagens, (ii) aggregated but not cross-linked collagen molecules, (iii) cross-linked collagens.

10 . The container of claim 10 in which the epithelial and mesenchymal cells in the seeding medium are introduced in multiple intervals, each interval followed by a period of rest.

11 . The container of claim 10 in which the interval is about 10 minutes and the period of rest is about 10 minutes.

12 . The container of claim 10 in which the seeding density is up to about 12 million cells per gram of wet weight of the biomatrix scaffolds and introduced during one or more intervals.

13 . The container of claim 10 in which the epithelial and mesenchymal or non-parenchymal cells in the seeding medium are introduced at a rate of ˜15 ml/min for one or more intervals.

14 . The container of claim 10 , in which the epithelial and mesenchymal cells in the seeding medium are introduced in 10 minute intervals, each followed by a 10 minute period of rest.

15 . The container of claim 10 in which the epithelial and mesenchymal cells in the seeding medium are is introduced at a rate of 1.3 ml/min after three intervals.

16 . The container of claim 1 in which the epithelial and mesenchymal cells comprise cells isolated from a fetal or neonatal organ.

17 . The container claim 1 in which the epithelial and mesenchymal cells comprise cells isolated from an adult or child donor

18 . The container of claim 1 in which the epithelial and mesenchymal cells comprise:
a. epithelial cells comprising one or more of stem cells, committed progenitors, diploid adult cells, polyploid adult cells, and/or terminally differentiated cells
and/or
b. mesenchymal cells comprising one or more of angioblasts, precursors to endothelia, mature endothelia, precursors to stellate cells, mature stellate cells, precursors to stroma, mature stroma, smooth muscle cells, precursors to hematopoietic cells, and/or mature hematopoietic cells.

19 . The container of claim 1 in which the epithelial and mesenchymal cells comprise:
a. epithelial cells comprising one or more of biliary tree stem cells, gall bladder-derived stem cells, hepatic stem cells, hepatoblasts, committed hepatocytic and biliary progenitors, axin2+ progenitors (such as axin2+ hepatic progenitors), mature parenchymal cells (such as hepatocytes, cholangiocytes), pancreatic stem cells, and pancreatic committed progenitors, islet cells, and/or acinar cells, and/or
b. mesenchymal cells comprising one or more of angioblasts, stellate cell precursors, stellate cells, mesenchymal stem cells, pericytes, smooth muscle cells, stromal cells, endothelial cell precursors, endothelial cells, hematopoetic cell precursors, and/or hematopoetic cells.

20 . The container of claim 1 in which the epithelial cells comprises one or more of stem cells and their descendants from the biliary tree, liver, pancreas, hepato-pancreatic common duct, and/or gall bladder and/or mesenchymal cells comprising one or more of angioblasts, precursors to endothelia and stellate cells, mesenchymal stem cells, stellate cells, stroma, smooth muscle cells, endothelia, bone marrow-derived stem cells, hematopoetic cell precursors, and/or hematopoetic cells.

21 . The container claim 1 in which the epithelial and mesenchymal cells consists of about 80% epithelial and 20% mesenchymal respectively

22 . The container of claim 1 in which the epithelial and mesenchymal cells comprise at least 50% stem cells and/or precursor cells.

23 . The container of claim 1 , wherein the epithelial and mesenchymal cells do not comprise any terminally differentiated hepatocytes and/or pancreatic cells.

24 . The container of claim 1 in which the biomatrix scaffold comprises one or more collagen associated matrix components comprising one or more of laminins, nidogen, elastins, proteoglycans, hyaluronaus, non-sulfated glycosaminoglycans, sulfated glycosaminoglycans, growth factors and/or cytokines associated with the matrix components.

25 . The container of claim 1 in which the biomatrix scaffold comprises greater than 20-50% of matrix-bound signaling molecules found in vivo.

26 . The container of claim 1 in which the biomatrix scaffold comprises a matrix remnant of the vascular tree of the tissue and/or wherein the matrix remnant provides vascular support of the cells in the bioengineered tissue

27 . A three-dimensional micro-organ generated in the container of claim 1 .

Assignees

• Univ North Carolina Chapel Hill

Inventors

• Hanson Ariel Dawn
• Yamauchi Mitsuo
• Wauthier Eliane Lucie
• Dinh Timothy Anh-Hieu
• SETHUPATHY Praveen
• Reid Lola M

Classifications

• A61L27/26

  Mixtures of macromolecular compounds · CPC title

• A61L27/24

  Collagen · CPC title

• A61L27/3604

  characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel · CPC title

• C12N5/067

  Hepatocytes · CPC title

• C12N2500/34

  Sugars · CPC title